Michael Barsch is a seasoned professional in clinical quality assurance and program management, currently serving as Global Program Head at Sandoz since October 2022. Prior to this role, Michael held various leadership positions at Novartis from January 2017 to October 2022, including Head External Service Provider QA (ad-interim) and Head Global Clinical Development QA Biosimilar Programs. Michael's experience at Sandoz also includes a role as Senior Clinical Quality Assurance Operations Manager from December 2015 to December 2016. Earlier career milestones include senior roles at UCB Biosciences GmbH and Antisense Pharma GmbH. Michael Barsch holds a Master of Science in Clinical Research Management from Wissenschaftliche Hochschule Lahr and a Staatsexamen in Pharmacy from Goethe Universität Frankfurt am Main.
This person is not in the org chart
This person is not in any teams
This person is not in any offices